शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEChemiesynth (Vapi) Limited· Chemicals & PetrochemicalsHighNeutral
Announced Wed, 12 Aug, 2026 · 16:11 IST

Q1 FY27 loss widens to ₹58.37 lakh; ₹15 Cr NCRPS issue approved

Pat NegativeEbitda Margin CompressionRelated Party TransactionsResults View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction

Awaiting price reaction for this filing.

AI summary

Chemiesynth Vapi posted Q1 FY27 revenue of ₹419.69 lakh, up 5.6 percent from ₹397.46 lakh YoY, but loss widened to ₹58.37 lakh from ₹45.63 lakh. Total expenses rose to ₹479.92 lakh from ₹443.09 lakh. FY26 PAT was a loss of ₹98.93 lakh with EPS of negative ₹3.22. The Board approved raising authorised share capital and issuing up to 1.5 crore 5 percent cumulative redeemable preference shares worth ₹15 crore privately to the promoter group. Statutory auditor gave an unqualified limited review report.

Likely market impact

Sustained losses and the private preference share placement to promoters could weigh on the stock. NCRPS adds an interest obligation without immediate equity dilution.